Hub : Traits :

Lupus

222 significantly associated models · 57 unique genes.

Significant Loci

#	chr	p0	p1	# assoc genes	# joint genes	best TWAS P	best SNP P	cond SNP P	% var exp	joint genes
1	2	190521054	192254289	4	2	3.1e-18	9.7e-66	1.4e-53	19	MFSD6 NAB1
2	3	57622089	59105913	2	1	1.8e-08	1.3e-07	6.3e-01	99	PXK
3	4	102093807	103243101	1	1	2.4e-07	4.5e-10	9.0e-05	60	BANK1
4	6	34065982	35552627	2	2	1.3e-09	3.3e-08	2.9e-02	84	TAF11 UHRF1BP1
5	7	127812871	129502461	6	10	1.5e-44	3.8e-45	NaN	NaN	ATP6V1F IRF5 RP11-286H14.6 TSPAN33
6	8	10265712	11891593	6	6	2.7e-16	5.2e-18	NaN	NaN	AF131215.2 AF131215.9 BLK FAM167A
7	11	198510	1423176	10	2	1.6e-12	3.5e-11	2.4e-02	88	HRAS TMEM80
8	11	34189564	35949179	2	2	2.4e-11	2.9e-11	9.8e-01	100	APIP CD44
9	12	128579481	130007356	1	1	2.1e-08	1.0e-07	4.8e-03	72	SLC15A4
10	16	30154740	31957368	7	7	1.4e-32	1.8e-46	NaN	NaN	BCL7C HSD3B7 ITGAD ITGAM MIR4519
11	17	37363793	38783469	4	1	8.1e-10	5.3e-07	9.1e-01	100	IKZF3
12	19	1473344	2923263	1	1	2.7e-07	3.8e-06	1.2e-01	89	DOT1L
13	19	9755448	11146499	2	2	3.0e-08	1.5e-12	9.6e-08	43	ICAM3 ICAM5
14	22	21075537	22685340	4	1	4.1e-15	8.3e-14	3.2e-01	98	CCDC116

Pleiotropic Associations

Trait	chisq ratio	# genes⁺	# genes⁺⁺	% genes⁺⁺	corr	corr P	genes
Schizophrenia (2018)	1.29	1	0	0.0	0.00	1.0e+00	DOT1L
Crohns Disease (2017)	1.76	2	1	2.2	0.00	1.0e+00	CCDC116 IKZF3
Irritable Bowel Disease (IBD)	2.20	2	2	4.4	0.00	1.0e+00	CCDC116 IKZF3
Ulcerative Colitis (UC)	3.45	3	1	2.2	0.96	1.7e-04	CCDC116 IKZF3 IRF5
Breast Cancer	1.02	1	0	0.0	0.00	1.0e+00	HRAS
Crohns Disease (2012)	1.69	1	1	2.2	0.00	1.0e+00	CCDC116
HDL Cholesterol	1.89	2	2	4.4	0.00	1.0e+00	CCDC116 IKZF3
Neuroticism (2016)	4.36	3	3	6.7	-1.00	6.6e-04	AF131215.2 AF131215.9 BLK
Primary Biliary Cirrhosis	11.74	8	2	4.4	0.99	6.6e-12	ATP6V1F ICAM3 ICAM5 IKZF3 IRF5 MFSD6 NAB1 TSPAN33
Rheumatoid Arthritis	6.85	7	1	2.2	0.99	2.8e-09	ATP6V1F BLK FAM167A ICAM3 ICAM5 IRF5 NAB1
Schizophrenia (2014)	1.28	1	0	0.0	0.00	1.0e+00	DOT1L
Triglycerides	2.19	1	0	0.0	0.00	1.0e+00	AF131215.9
Ulcerative Colitis	4.54	2	1	2.2	-0.01	9.9e-01	IKZF3 IRF5
Blood Eosinophil Count	1.99	8	4	8.9	-0.70	4.9e-03	BCL7C CCDC116 HRAS IKZF3 IRF5 MIR4519 NAB1 RP11-286H14.6
Blood Platelet Count	1.37	9	3	6.7	-0.60	1.8e-02	BANK1 HRAS ICAM3 ICAM5 IKZF3 IRF5 NAB1 TSPAN33 UHRF1BP1
Blood Red Count	1.11	7	4	8.9	-0.28	5.0e-01	DOT1L HSD3B7 IKZF3 ITGAM MIR4519 NAB1 PXK
Blood White Count	2.55	7	4	8.9	-0.66	1.1e-01	BCL7C CCDC116 HRAS ICAM3 ICAM5 IKZF3 MIR4519
Heel T-Score	1.89	8	4	8.9	-0.45	1.6e-01	BCL7C CCDC116 CD44 DOT1L ICAM3 IRF5 MIR4519 NAB1
BMI	1.38	7	2	4.4	0.32	4.8e-01	BCL7C ICAM3 ICAM5 MIR4519 PXK TAF11 UHRF1BP1
Height	0.77	9	5	11.1	-0.21	4.8e-01	BANK1 CCDC116 DOT1L HRAS ICAM3 IRF5 NAB1 TAF11 UHRF1BP1
Waist Hip Ratio (WHR)	1.11	3	2	4.4	0.00	1.0e+00	DOT1L HRAS UHRF1BP1
Systolic Blood Pressure	1.22	5	2	4.4	-0.46	3.6e-01	BANK1 CCDC116 DOT1L IRF5 NAB1
Allergy or Eczema	2.46	6	2	4.4	-0.10	8.5e-01	BLK CCDC116 FAM167A ICAM3 ICAM5 IKZF3
Cardiovascular Disease	1.13	2	0	0.0	0.00	1.0e+00	BANK1 ICAM5
Hypothyroidism (self reported)	4.38	9	2	4.4	0.86	1.9e-04	CCDC116 IKZF3 IRF5 MFSD6 NAB1 PXK SLC15A4 TMEM80 UHRF1BP1
Respiratory disease	3.16	2	1	2.2	0.00	1.0e+00	ICAM3 IKZF3
Lung FEV1/FVC ratio	0.94	5	1	2.2	0.18	7.7e-01	APIP HRAS ICAM3 IKZF3 ITGAD
Lung FVC	0.82	2	0	0.0	0.00	1.0e+00	DOT1L IKZF3
Hair Pigment	0.08	1	0	0.0	0.00	1.0e+00	CD44
Hand grip strength (left)	1.73	1	0	0.0	0.00	1.0e+00	BANK1
Sensitivity / hurt feelings	2.86	3	2	4.4	-0.99	7.2e-03	AF131215.2 AF131215.9 BLK
Relative age of first facial hair	1.01	1	0	0.0	0.00	1.0e+00	APIP
Systolic blood pressure, automated reading	2.67	5	3	6.7	0.75	5.2e-02	AF131215.2 AF131215.9 BLK DOT1L NAB1
Impedance of leg (right)	1.97	5	3	6.7	-0.96	5.8e-04	AF131215.2 AF131215.9 BCL7C BLK UHRF1BP1
Leg fat-free mass (left)	1.13	6	2	4.4	0.92	2.9e-03	AF131215.2 AF131215.9 BCL7C ITGAM MIR4519 UHRF1BP1
Trunk fat percentage	1.19	4	1	2.2	0.89	1.1e-01	BCL7C ITGAM MIR4519 UHRF1BP1
Hand grip strength (right)	1.77	2	0	0.0	0.00	1.0e+00	DOT1L IRF5
Current tobacco smoking	1.97	1	0	0.0	0.00	1.0e+00	AF131215.9
Fed-up feelings	2.41	2	2	4.4	0.00	1.0e+00	AF131215.2 AF131215.9
Taking other prescription medications	1.46	1	0	0.0	0.00	1.0e+00	IKZF3
Age when periods started (menarche)	1.55	2	0	0.0	0.00	1.0e+00	BANK1 IRF5
Heel bone mineral density (BMD) T-score, automated (left)	4.46	4	4	8.9	0.97	1.8e-03	AF131215.2 AF131215.9 BLK CD44
High blood pressure	2.64	6	2	4.4	0.73	6.5e-02	AF131215.2 AF131215.9 BCL7C BLK DOT1L ICAM5
Hayfever, allergic rhinitis or eczema	2.23	4	2	4.4	0.34	6.6e-01	CCDC116 ICAM3 ICAM5 IKZF3
Medication: Levothyroxine sodium	4.20	6	1	2.2	0.58	1.7e-01	AF131215.2 AF131215.9 IRF5 MFSD6 NAB1 UHRF1BP1
Sitting height	0.83	4	1	2.2	0.32	6.8e-01	CCDC116 DOT1L HRAS NAB1
Body mass index (BMI)	2.61	7	5	11.1	0.92	1.3e-03	AF131215.2 AF131215.9 BCL7C BLK ITGAM MIR4519 UHRF1BP1
Impedance of leg (left)	2.05	5	3	6.7	-0.96	5.6e-04	AF131215.2 AF131215.9 BLK CCDC116 UHRF1BP1
Leg predicted mass (left)	1.12	6	2	4.4	0.93	2.8e-03	AF131215.2 AF131215.9 BCL7C ITGAM MIR4519 UHRF1BP1
Trunk fat mass	1.27	5	1	2.2	0.91	3.1e-02	AF131215.9 BCL7C ITGAM MIR4519 UHRF1BP1
Waist circumference	1.09	4	1	2.2	0.94	6.1e-02	BCL7C ITGAM MIR4519 UHRF1BP1
Nervous feelings	3.93	3	3	6.7	-1.00	1.9e-03	AF131215.2 AF131215.9 BLK
Forced vital capacity (FVC)	1.37	3	0	0.0	0.00	1.0e+00	NAB1 TAF11 UHRF1BP1
Heel bone mineral density (BMD) T-score, automated (right)	4.74	4	4	8.9	0.97	1.0e-03	AF131215.2 AF131215.9 BLK CD44
Mouth/teeth dental problems	2.45	1	0	0.0	0.10	9.0e-01	IRF5
Allergy	2.49	4	1	2.2	-0.05	9.5e-01	CCDC116 ICAM3 ICAM5 IKZF3
Hayfever/allergic rhinitis (self-reported)	2.47	2	1	2.2	0.00	1.0e+00	BCL7C IKZF3
Neuroticism score	4.24	3	3	6.7	-0.99	1.5e-03	AF131215.2 AF131215.9 BLK
Weight	1.39	6	4	8.9	0.94	1.4e-03	AF131215.2 AF131215.9 BCL7C ITGAM MIR4519 UHRF1BP1
Impedance of arm (right)	2.11	5	2	4.4	-0.70	1.2e-01	AF131215.2 AF131215.9 BCL7C BLK ICAM5
Arm fat percentage (right)	1.75	7	2	4.4	0.91	1.9e-03	AF131215.2 AF131215.9 BCL7C BLK ITGAM MIR4519 UHRF1BP1
Trunk fat-free mass	0.78	3	0	0.0	0.00	1.0e+00	AF131215.2 AF131215.9 DOT1L
Hip circumference	1.88	6	5	11.1	0.94	1.6e-03	AF131215.2 AF131215.9 BCL7C ITGAM MIR4519 UHRF1BP1
Worrier / anxious feelings	4.42	3	3	6.7	-1.00	3.6e-03	AF131215.2 AF131215.9 BLK
Forced expiratory volume in 1-second (FEV1)	1.53	2	1	2.2	0.00	1.0e+00	AF131215.9 TAF11
Serious illness, injury or assault of a close relative in last 2 years	1.34	1	0	0.0	0.00	1.0e+00	AF131215.9
Mouth/teeth dental problems: Dentures	1.60	1	0	0.0	0.00	1.0e+00	AF131215.9
Asthma	3.25	2	1	2.2	0.00	1.0e+00	ICAM3 IKZF3
Forced expiratory volume in 1-second (FEV1), Best measure	1.31	2	1	2.2	0.00	1.0e+00	TAF11 UHRF1BP1
Impedance of arm (left)	1.87	4	2	4.4	-0.62	2.6e-01	AF131215.2 AF131215.9 BCL7C ICAM5
Arm fat mass (right)	1.84	6	4	8.9	0.91	4.2e-03	AF131215.2 AF131215.9 BCL7C ITGAM MIR4519 UHRF1BP1
Trunk predicted mass	0.78	3	0	0.0	0.00	1.0e+00	AF131215.2 AF131215.9 DOT1L
Standing height	0.98	7	1	2.2	-0.44	1.6e-01	AF131215.9 CCDC116 DOT1L IRF5 NAB1 TAF11 UHRF1BP1
Length of working week for main job	2.16	1	0	0.0	0.00	1.0e+00	SLC15A4
Tense / 'highly strung'	2.53	3	2	4.4	-0.99	1.4e-02	AF131215.2 AF131215.9 BLK
Peak expiratory flow (PEF)	1.85	4	0	0.0	-1.00	4.2e-04	AF131215.2 AF131215.9 BLK TAF11
Gout (self-reported)	2.34	1	0	0.0	0.00	1.0e+00	IRF5
Hypothyroidism/myxoedema (self-reported)	4.98	9	2	4.4	0.45	1.4e-01	AF131215.2 AF131215.9 BLK CCDC116 IRF5 MFSD6 NAB1 PXK UHRF1BP1
Medication: Ventolin 100micrograms inhaler	1.90	1	1	2.2	0.00	1.0e+00	IKZF3
Forced vital capacity (FVC), Best measure	1.01	2	0	0.0	0.00	1.0e+00	TAF11 UHRF1BP1
Body fat percentage	1.38	4	1	2.2	0.89	1.1e-01	BCL7C ITGAM MIR4519 UHRF1BP1
Leg fat percentage (right)	1.60	6	1	2.2	0.91	1.2e-02	AF131215.2 AF131215.9 BCL7C ITGAM MIR4519 UHRF1BP1
Arm fat-free mass (right)	1.13	6	2	4.4	0.94	6.0e-03	AF131215.2 AF131215.9 BCL7C DOT1L ITGAM MIR4519
Comparative body size at age 10	2.34	3	2	4.4	0.84	1.6e-01	AF131215.2 AF131215.9 DOT1L
Worry too long after embarrassment	2.70	3	2	4.4	-1.00	3.8e-03	AF131215.2 AF131215.9 BLK
Seen a psychiatrist for nerves, anxiety, tension or depression	1.10	1	0	0.0	0.00	1.0e+00	NAB1
Wheeze or whistling in the chest in last year	1.67	1	1	2.2	0.00	1.0e+00	IKZF3
Qualifications: College or University degree	0.73	1	0	0.0	0.00	1.0e+00	IKZF3
Medication: Blood pressure	1.46	1	0	0.0	0.00	1.0e+00	AF131215.9
Whole body fat mass	1.50	6	2	4.4	0.92	3.5e-03	AF131215.2 AF131215.9 BCL7C ITGAM MIR4519 UHRF1BP1
Leg fat mass (right)	1.89	7	4	8.9	0.75	3.3e-02	AF131215.2 AF131215.9 BCL7C ICAM5 ITGAM MIR4519 UHRF1BP1
Arm predicted mass (right)	1.19	5	2	4.4	0.94	6.0e-03	AF131215.2 AF131215.9 BCL7C ITGAM MIR4519
Pulse rate, automated reading	0.91	2	0	0.0	0.00	1.0e+00	MFSD6 NAB1
Comparative height size at age 10	0.83	3	1	2.2	0.00	1.0e+00	BANK1 CCDC116 DOT1L
Suffer from 'nerves'	2.43	3	2	4.4	-1.00	1.4e-03	AF131215.2 AF131215.9 BLK
Overall health rating	1.50	1	0	0.0	0.00	1.0e+00	AF131215.2
Age at last live birth	1.63	1	0	0.0	0.00	1.0e+00	AF131215.9
Hypertension (Self-reported)	2.55	5	2	4.4	0.65	1.6e-01	AF131215.2 AF131215.9 BLK DOT1L ICAM5
Whole body fat-free mass	0.89	4	2	4.4	0.99	7.5e-03	AF131215.2 AF131215.9 BCL7C DOT1L
Leg fat-free mass (right)	1.04	4	2	4.4	0.97	5.6e-03	AF131215.2 AF131215.9 BCL7C UHRF1BP1
Arm fat percentage (left)	1.83	7	2	4.4	0.91	1.7e-03	AF131215.2 AF131215.9 BCL7C BLK ITGAM MIR4519 UHRF1BP1
Mood swings	2.32	3	2	4.4	-0.99	9.8e-03	AF131215.2 AF131215.9 BLK
Long-standing illness, disability or infirmity	1.20	1	0	0.0	0.00	1.0e+00	CCDC116
Mouth/teeth dental problems: Mouth ulcers	4.15	1	1	2.2	0.96	7.4e-04	IRF5
Asthma (self-reported)	3.25	1	1	2.2	0.00	1.0e+00	IKZF3
Smoking status: Current	1.92	2	0	0.0	0.00	1.0e+00	AF131215.2 AF131215.9
Forced expiratory volume in 1-second (FEV1), predicted percentage	2.08	3	0	0.0	0.00	1.0e+00	AF131215.9 BCL7C IKZF3
Whole body water mass	0.91	4	2	4.4	0.99	8.8e-03	AF131215.2 AF131215.9 BCL7C DOT1L
Leg predicted mass (right)	1.04	4	2	4.4	0.97	5.2e-03	AF131215.2 AF131215.9 BCL7C UHRF1BP1
Arm fat mass (left)	1.87	7	4	8.9	0.93	8.4e-04	AF131215.2 AF131215.9 BCL7C BLK ITGAM MIR4519 UHRF1BP1
Number of self-reported non-cancer illnesses	1.37	2	0	0.0	0.00	1.0e+00	IKZF3 RP11-286H14.6
Miserableness	2.39	2	2	4.4	0.00	1.0e+00	AF131215.2 AF131215.9
Guilty feelings	1.86	2	0	0.0	0.00	1.0e+00	AF131215.2 AF131215.9
Medication: Blood pressure	2.49	2	0	0.0	0.00	1.0e+00	AF131215.2 AF131215.9
High cholesterol (Self-reported)	0.95	1	0	0.0	0.00	1.0e+00	ICAM3
Medication: Bendroflumethiazide	2.50	3	0	0.0	1.00	8.9e-05	AF131215.2 AF131215.9 BCL7C
Basal metabolic rate	1.03	7	2	4.4	0.94	1.9e-03	AF131215.2 AF131215.9 BCL7C DOT1L ITGAM MIR4519 UHRF1BP1
Leg fat percentage (left)	1.67	6	2	4.4	0.91	4.4e-03	AF131215.2 AF131215.9 BCL7C ITGAM MIR4519 UHRF1BP1
Arm fat-free mass (left)	1.13	6	2	4.4	0.93	6.3e-03	AF131215.2 AF131215.9 BCL7C DOT1L ITGAM MIR4519
Average weekly beer plus cider intake	2.10	3	0	0.0	-1.00	2.9e-03	AF131215.2 AF131215.9 BLK
Irritability	4.23	3	3	6.7	-0.98	2.5e-03	AF131215.2 AF131215.9 BLK
Risk taking	1.49	2	0	0.0	0.00	1.0e+00	AF131215.2 AF131215.9
Fractured/broken bones in last 5 years	1.83	2	0	0.0	0.00	1.0e+00	ITGAM MIR4519
Diastolic blood pressure, automated reading	2.89	5	3	6.7	0.95	9.5e-04	AF131215.2 AF131215.9 BANK1 BLK FAM167A
Myopia	1.53	1	0	0.0	0.00	1.0e+00	IKZF3
Vascular/heart problems diagnosed by doctor	2.28	4	1	2.2	-1.00	7.6e-05	AF131215.2 AF131215.9 BCL7C BLK
Cholesterol lowering medication	1.39	2	0	0.0	0.00	1.0e+00	BCL7C MIR4519
Impedance of whole body	2.06	4	3	6.7	-0.99	1.0e-03	AF131215.2 AF131215.9 BCL7C BLK
Leg fat mass (left)	1.85	6	4	8.9	0.92	3.4e-03	AF131215.2 AF131215.9 BCL7C ITGAM MIR4519 UHRF1BP1
Arm predicted mass (left)	1.19	5	2	4.4	0.93	2.3e-02	AF131215.2 AF131215.9 BCL7C ITGAM MIR4519

Associations by panel

study	tissue	# hits	% hits/tests	avg chisq
GTEx	Adipose Subcutaneous	4	0.115	1.5
GTEx	Adipose Visceral Omentum	6	0.296	1.6
GTEx	Adrenal Gland	3	0.208	1.6
GTEx	Artery Aorta	7	0.236	1.5
GTEx	Artery Coronary	2	0.170	1.8
GTEx	Artery Tibial	4	0.107	1.5
GTEx	Brain Caudate basal ganglia	1	0.110	1.5
GTEx	Brain Cerebellar Hemisphere	0	0.000	1.5
GTEx	Brain Cerebellum	4	0.203	1.5
GTEx	Brain Cortex	1	0.097	1.6
GTEx	Brain Frontal Cortex BA9	1	0.109	1.6
GTEx	Brain Hippocampus	0	0.000	1.7
GTEx	Brain Hypothalamus	0	0.000	1.5
GTEx	Brain Nucleus accumbens basal ganglia	0	0.000	1.5
GTEx	Brain Putamen basal ganglia	1	0.162	1.8
GTEx	Breast Mammary Tissue	2	0.102	1.5
GTEx	Breast Mammary Tissue (Male)	1	0.084	1.6
GTEx	Breast Mammary Tissue (Female)	2	0.123	1.4
GTEx	Cells EBV-transformed lymphocytes	1	0.071	1.6
GTEx	Cells Transformed fibroblasts	2	0.048	1.5
GTEx	Colon Sigmoid	2	0.138	1.6
GTEx	Colon Transverse	2	0.098	1.6
GTEx	Esophagus Gastroesophageal Junction	2	0.139	1.5
GTEx	Esophagus Mucosa	5	0.151	1.5
GTEx	Esophagus Muscularis	6	0.187	1.6
GTEx	Heart Atrial Appendage	3	0.191	1.7
GTEx	Heart Left Ventricle	1	0.066	1.6
GTEx	Liver	1	0.141	1.6
GTEx	Lung	3	0.105	1.5
GTEx	Muscle Skeletal	3	0.104	1.5
GTEx	Nerve Tibial	5	0.116	1.5
GTEx	Ovary	3	0.332	1.6
GTEx	Pancreas	4	0.246	1.6
GTEx	Pituitary	1	0.090	1.6
GTEx	Prostate	1	0.121	1.5
GTEx	Skin Not Sun Exposed Suprapubic	5	0.204	1.5
GTEx	Skin Sun Exposed Lower leg	4	0.111	1.6
GTEx	Small Intestine Terminal Ileum	2	0.440	1.7
GTEx	Spleen	2	0.143	1.7
GTEx	Stomach	0	0.000	1.5
GTEx	Testis	4	0.127	1.5
GTEx	Thyroid	6	0.151	1.5
GTEx	Uterus	0	0.000	1.6
GTEx	Vagina	0	0.000	1.6
GTEx	Whole Blood	5	0.252	1.7
METSIM	Adipose	9	0.196	1.5
NTR	Blood	3	0.125	1.5
ROSMAP	Brain Pre-frontal Cortex	6	0.137	1.5
YFS	Blood	4	0.087	1.5
CommonMind	Brain Pre-frontal Cortex	5	0.093	1.4
The Cancer Genome Atlas	Bladder Urothelial Carcinoma	4	0.242	1.6
The Cancer Genome Atlas	Breast Invasive Carcinoma	9	0.205	1.5
The Cancer Genome Atlas	Cervical Squamous Cell Carcinoma	2	0.183	1.6
The Cancer Genome Atlas	Colon Adenocarcinoma	3	0.146	1.5
The Cancer Genome Atlas	Esophageal Carcinoma	0	0.000	1.4
The Cancer Genome Atlas	Glioblastoma Multiforme	3	0.295	1.6
The Cancer Genome Atlas	Head and Neck Squamous Cell Carcinoma	3	0.110	1.5
The Cancer Genome Atlas	Kidney Renal Clear Cell Carcinoma	6	0.147	1.5
The Cancer Genome Atlas	Kidney Renal Papillary Cell Carcinoma	5	0.245	1.7
The Cancer Genome Atlas	Brain Lower Grade Glioma	6	0.140	1.5
The Cancer Genome Atlas	Liver Hepatocellular Carcinoma	2	0.182	1.6
The Cancer Genome Atlas	Lung Adenocarcinoma	1	0.034	1.5
The Cancer Genome Atlas	Lung Squamous Cell Carcinoma	3	0.120	1.5
The Cancer Genome Atlas	Ovarian Serous Cystadenocarcinoma	3	0.189	1.5
The Cancer Genome Atlas	Pancreatic Adenocarcinoma	4	0.242	1.6
The Cancer Genome Atlas	Pheochromocytoma and Paraganglioma	1	0.076	1.5
The Cancer Genome Atlas	Prostate Adenocarcinoma	7	0.152	1.5
The Cancer Genome Atlas	Rectum Adenocarcinoma	3	0.435	1.8
The Cancer Genome Atlas	Soft Tissue Sarcoma	1	0.094	1.6
The Cancer Genome Atlas	Skin Cutaneous Melanoma	1	0.188	1.6
The Cancer Genome Atlas	Stomach Adenocarcinoma	4	0.238	1.5
The Cancer Genome Atlas	Testicular Germ Cell Tumors	1	0.079	1.6
The Cancer Genome Atlas	Thyroid Carcinoma	9	0.175	1.5
The Cancer Genome Atlas	Uterine Corpus Endometrial Carcinoma	2	0.396	1.6